| | |
| 0059 |
2:30 PM | Mechanism of HEMA Mediated Apoptosis in Dental Pulp Stromal Cells
A. PARANJPE, W. HUME, and A. JEWETT, University of California at Los Angeles, USA |
| 0060 |
2:45 PM | Reduced, Nonprotein Thiols Inhibit Activation and Function of MMPs
S. MALLERY, M. HORAN, and P. PEI, Ohio State University -, Columbus, USA |
| 0061 |
3:00 PM | N-Acetyl-L-Cysteine Upregulates TIMP-1 And TIMP-2 Expression In Squamous Cell Carcinoma
M. HORAN, P. PEI, G. CHACON, and S. MALLERY, Ohio State University, Columbus, USA |
| 0062 |
3:15 PM | Anesthetic Characteristics of 4%Articaine Containing 1:100,000, 1:200,000, or no Epinephrine
S.G. BOYNES1, E.V. HERSH2, T. SOLLECITO3, S.S. DEROSSI3, J.M. GOODSON4, J.S. LEONEL4, C. FLOROS4, C. PETERSON5, and P.A. MOORE1, 1University of Pittsburgh, PA, USA, 2University of Pennsylvania, School of Dental Medicine, Philadelphia, USA, 3University of Pennsylvania, PHiladelphia, USA, 4Forsyth Institute, Boston, MA, USA, 5Novocol Pharmaceutical of Canada, Cambridge, Canada |
| 0063 |
3:30 PM | Hemostatic Efficacy of 4%Articaine HCl with 1:200,000 or 1:100,000 epinephrine
P.A. MOORE1, R.A. DELIE1, A.L. LUDOVICY1, E.V. HERSH2, J. KOROSTOFF3, S. JOHNSON3, J.M. GOODSON4, S. HALEM4, M. PAYLS4, and C. PETERSON5, 1University of Pittsburgh, PA, USA, 2University of Pennsylvania, School of Dental Medicine, Philadelphia, USA, 3University of Pennsylvania, Philadelphia, USA, 4Forsyth Institute, Boston, MA, USA, 5Novocol Pharmaceutical of Canada, Cambridge, Canada |
| 0064 |
3:45 PM | Pharmacokinetics and Cardiovascular Effects of Articaine with 1:100,000/1:200,000 Epinephrine
H. GIANNAKOPOULOS1, L.M. LEVIN2, A. MOSENKIS2, R.R. TOWNSEND2, S.A. SECRETO1, C. PETERSON3, P.A. MOORE4, and E.V. HERSH1, 1University of Pennsylvania, School of Dental Medicine, Philadelphia, USA, 2University of Pennsylvania, Philadelphia, USA, 3Novocol Pharmaceutical of Canada, Cambridge, Canada, 4University of Pittsburgh, PA, USA |
|